KILITCH DRUGS (INDIA)
Back to Income Statement
|
KILITCH DRUGS (INDIA) Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹7.37 Cr | ₹3.67 Cr | ₹0.84 Cr | ₹3.83 Cr | ₹5.15 Cr |
What is the latest Consolidated Net Profit of KILITCH DRUGS (INDIA) ?
Year | Consolidated Net Profit |
---|---|
Mar2023 | ₹7.37 Cr |
Mar2022 | ₹3.67 Cr |
Mar2021 | ₹0.84 Cr |
Mar2020 | ₹3.83 Cr |
Mar2019 | ₹5.15 Cr |
How is Consolidated Net Profit of KILITCH DRUGS (INDIA) Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2023 | ₹7.37 Cr | 100.68 | |
Mar2022 | ₹3.67 Cr | 335.99 | |
Mar2021 | ₹0.84 Cr | -78.02 | |
Mar2020 | ₹3.83 Cr | -25.67 | |
Mar2019 | ₹5.15 Cr | - |
Compare Consolidated Net Profit of peers of KILITCH DRUGS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KILITCH DRUGS (INDIA) | ₹554.5 Cr | 1.3% | -1.9% | 57% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,290.0 Cr | -0.9% | 0.9% | 62.6% | Stock Analytics | |
CIPLA | ₹113,357.0 Cr | 3.5% | 4.2% | 51.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹111,134.0 Cr | 12.2% | 18% | 103.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,235.0 Cr | 0.8% | 5.6% | 19.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,001.5 Cr | -1% | -2.4% | 28.4% | Stock Analytics |
KILITCH DRUGS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KILITCH DRUGS (INDIA) | 1.3% |
-1.9% |
57% |
SENSEX | 1.7% |
1.5% |
18.7% |
You may also like the below Video Courses